PRODH2
Hydroxyproline dehydrogenase
Also known as: HSPOX1, HYPDH_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UF12
- Gene
- PRODH2
- Ensembl
- ENSG00000250799
- Chromosome
- 19
- Canonical length
- 460 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene catalyzes the first step in the catabolism of trans-4-hydroxy-L-proline, an amino acid derivative obtained through food intake and collagen turnover. One of the downstream products of this catabolism is glyoxylate, which in people with disorders of glyoxalate metabolism can lead to an increase in oxalate levels and the formation of calcium-oxalate kidney stones. Therefore, this gene may serve as a therapeutic target against primary hyperoxalurias (PH). This gene is similar to proline dehydrogenase (oxidase) 1, a mitochondrial enzyme that catalyzes the first step in proline catabolism. [provided by RefSeq, Jan 2017]
Canonical amino-acid sequenceUniProt
460 residues, UniProt reviewed canonical sequence.
>Q9UF12|PRODH2
1 MLRTCYVLCS QAGPPSRGWQ SLSFDGGAFH LKGTGELTRA LLVLRLCAWP PLVTHGLLLQ
61 AWSRRLLGSR LSGAFLRASV YGQFVAGETA EEVKGCVQQL RTLSLRPLLA VPTEEEPDSA
121 AKSGEAWYEG NLGAMLRCVD LSRGLLEPPS LAEASLMQLK VTALTSTRLC KELASWVRRP
181 GASLELSPER LAEAMDSGQN LQVSCLNAEQ NQHLRASLSR LHRVAQYARA QHVRLLVDAE
241 YTSLNPALSL LVAALAVRWN SPGEGGPWVW NTYQACLKDT FERLGRDAEA AHRAGLAFGV
301 KLVRGAYLDK ERAVAQLHGM EDPTQPDYEA TSQSYSRCLE LMLTHVARHG PMCHLMVASH
361 NEESVRQATK RMWELGIPLD GTVCFGQLLG MCDHVSLALG QAGYVVYKSI PYGSLEEVIP
421 YLIRRAQENR SVLQGARREQ ELLSQELWRR LLPGCRRIPHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRODH2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 188 nTPM
Expression across tissuesHPA
Tissue
- liver: 188 nTPM
- kidney: 154 nTPM
- pancreas: 4.8 nTPM
- testis: 1.2 nTPM
- duodenum: 0.4 nTPM
- lymph node: 0.4 nTPM
Single-cell type
- proximal tubule cells: 326 nCPM
- hepatocytes: 191 nCPM
- podocytes: 56 nCPM
- epididymal efferent duct absorptive cells: 26 nCPM
- pdcs: 25 nCPM
- renal connecting tubule cells: 20 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 0.6 nTPM
- cerebral cortex: 0.3 nTPM
- amygdala: 0.2 nTPM
- basal ganglia: 0.2 nTPM
- hippocampal formation: 0.2 nTPM
- thalamus: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.19
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.12
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- FAD binding
- proline dehydrogenase activity
- oxidoreductase activity, acting on the CH-NH group of donors
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRODH2 as an antibody target. Whether an autoantibody or antibody against PRODH2 could matter depends on whether native PRODH2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRODH2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRODH2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...